Quantification in positron emission tomography for research in pharmacology and drug development

Positron emission tomography (PET) is a quantitative in vivo tracer technique, enabling images of the distribution of biochemical, physiological and pharmacological functions in living tissue, at a resolution of a few millimetres. Applications include the imaging of blood flow rate, metabolic rate a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nuclear medicine communications 2004-07, Vol.25 (7), p.643-646
Hauptverfasser: Cunningham, V.J, Gunn, R.N, Matthews, J.C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 646
container_issue 7
container_start_page 643
container_title Nuclear medicine communications
container_volume 25
creator Cunningham, V.J
Gunn, R.N
Matthews, J.C
description Positron emission tomography (PET) is a quantitative in vivo tracer technique, enabling images of the distribution of biochemical, physiological and pharmacological functions in living tissue, at a resolution of a few millimetres. Applications include the imaging of blood flow rate, metabolic rate and neuroreceptor distribution and function. These applications are playing an increasing role in drug development. This brief article seeks to emphasize how these applications of PET need to rest on a solid quantitative foundation.
doi_str_mv 10.1097/01.mnm.0000134330.38536.bc
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66657310</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66657310</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3603-9b4bc1c423f9b1fabe750c8c813088e6953257efafe89631c39d1d1669a2f9a13</originalsourceid><addsrcrecordid>eNpFkM1u1TAQRr0A0VL6CihiwS6pJ5M4NjtUUUCqVCHB2nWc8U3aJA52QnXfHt8fqd7YMzrzjXUY-wS8AK6aGw7FNE8FTwewQuQFyhpF0do37JJDhTkKFBfsfYxPiZEomnfsAuqSy0qqS_b4azPzOrjBmnXwczbM2eLjsIb0pmmI8dBc_eR3wSz9PnM-ZIEimWD7I9ybMBnrR7_bZ2busi5su6yjfzT6ZaJ5_cDeOjNGuj7fV-zP3bfftz_y-4fvP2-_3ucWBcdctVVrwVYlOtWCMy01NbfSSkAuJQlVY1k35IwjqQSCRdVBB0IoUzplAK_Y51PuEvzfjeKq0-8tjaOZyW9RCyHqBoEn8MsJtMHHGMjpJQyTCXsNXB-cag46OdWvTvXRqW5tGv543rK1E3Wvo2ehCahOwIsfVwrxedxeKOiezLj2x0hRIuQl5xVvUpUfWoj_AfSlh9M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66657310</pqid></control><display><type>article</type><title>Quantification in positron emission tomography for research in pharmacology and drug development</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Cunningham, V.J ; Gunn, R.N ; Matthews, J.C</creator><creatorcontrib>Cunningham, V.J ; Gunn, R.N ; Matthews, J.C</creatorcontrib><description>Positron emission tomography (PET) is a quantitative in vivo tracer technique, enabling images of the distribution of biochemical, physiological and pharmacological functions in living tissue, at a resolution of a few millimetres. Applications include the imaging of blood flow rate, metabolic rate and neuroreceptor distribution and function. These applications are playing an increasing role in drug development. This brief article seeks to emphasize how these applications of PET need to rest on a solid quantitative foundation.</description><identifier>ISSN: 0143-3636</identifier><identifier>DOI: 10.1097/01.mnm.0000134330.38536.bc</identifier><identifier>PMID: 15208489</identifier><language>eng</language><publisher>England: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Algorithms ; Animals ; Brain - blood supply ; Brain - diagnostic imaging ; Brain - metabolism ; Brain Mapping - methods ; Drug Design ; Fluorodeoxyglucose F18 - pharmacokinetics ; Humans ; Image Enhancement - methods ; Image Interpretation, Computer-Assisted - methods ; Pharmacology - methods ; Positron-Emission Tomography - methods ; Positron-Emission Tomography - trends ; Radiopharmaceuticals - pharmacokinetics ; Research Design ; Sensory Receptor Cells - metabolism</subject><ispartof>Nuclear medicine communications, 2004-07, Vol.25 (7), p.643-646</ispartof><rights>2004 Lippincott Williams &amp; Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3603-9b4bc1c423f9b1fabe750c8c813088e6953257efafe89631c39d1d1669a2f9a13</citedby><cites>FETCH-LOGICAL-c3603-9b4bc1c423f9b1fabe750c8c813088e6953257efafe89631c39d1d1669a2f9a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15208489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cunningham, V.J</creatorcontrib><creatorcontrib>Gunn, R.N</creatorcontrib><creatorcontrib>Matthews, J.C</creatorcontrib><title>Quantification in positron emission tomography for research in pharmacology and drug development</title><title>Nuclear medicine communications</title><addtitle>Nucl Med Commun</addtitle><description>Positron emission tomography (PET) is a quantitative in vivo tracer technique, enabling images of the distribution of biochemical, physiological and pharmacological functions in living tissue, at a resolution of a few millimetres. Applications include the imaging of blood flow rate, metabolic rate and neuroreceptor distribution and function. These applications are playing an increasing role in drug development. This brief article seeks to emphasize how these applications of PET need to rest on a solid quantitative foundation.</description><subject>Algorithms</subject><subject>Animals</subject><subject>Brain - blood supply</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - metabolism</subject><subject>Brain Mapping - methods</subject><subject>Drug Design</subject><subject>Fluorodeoxyglucose F18 - pharmacokinetics</subject><subject>Humans</subject><subject>Image Enhancement - methods</subject><subject>Image Interpretation, Computer-Assisted - methods</subject><subject>Pharmacology - methods</subject><subject>Positron-Emission Tomography - methods</subject><subject>Positron-Emission Tomography - trends</subject><subject>Radiopharmaceuticals - pharmacokinetics</subject><subject>Research Design</subject><subject>Sensory Receptor Cells - metabolism</subject><issn>0143-3636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM1u1TAQRr0A0VL6CihiwS6pJ5M4NjtUUUCqVCHB2nWc8U3aJA52QnXfHt8fqd7YMzrzjXUY-wS8AK6aGw7FNE8FTwewQuQFyhpF0do37JJDhTkKFBfsfYxPiZEomnfsAuqSy0qqS_b4azPzOrjBmnXwczbM2eLjsIb0pmmI8dBc_eR3wSz9PnM-ZIEimWD7I9ybMBnrR7_bZ2busi5su6yjfzT6ZaJ5_cDeOjNGuj7fV-zP3bfftz_y-4fvP2-_3ucWBcdctVVrwVYlOtWCMy01NbfSSkAuJQlVY1k35IwjqQSCRdVBB0IoUzplAK_Y51PuEvzfjeKq0-8tjaOZyW9RCyHqBoEn8MsJtMHHGMjpJQyTCXsNXB-cag46OdWvTvXRqW5tGv543rK1E3Wvo2ehCahOwIsfVwrxedxeKOiezLj2x0hRIuQl5xVvUpUfWoj_AfSlh9M</recordid><startdate>200407</startdate><enddate>200407</enddate><creator>Cunningham, V.J</creator><creator>Gunn, R.N</creator><creator>Matthews, J.C</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200407</creationdate><title>Quantification in positron emission tomography for research in pharmacology and drug development</title><author>Cunningham, V.J ; Gunn, R.N ; Matthews, J.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3603-9b4bc1c423f9b1fabe750c8c813088e6953257efafe89631c39d1d1669a2f9a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Algorithms</topic><topic>Animals</topic><topic>Brain - blood supply</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - metabolism</topic><topic>Brain Mapping - methods</topic><topic>Drug Design</topic><topic>Fluorodeoxyglucose F18 - pharmacokinetics</topic><topic>Humans</topic><topic>Image Enhancement - methods</topic><topic>Image Interpretation, Computer-Assisted - methods</topic><topic>Pharmacology - methods</topic><topic>Positron-Emission Tomography - methods</topic><topic>Positron-Emission Tomography - trends</topic><topic>Radiopharmaceuticals - pharmacokinetics</topic><topic>Research Design</topic><topic>Sensory Receptor Cells - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cunningham, V.J</creatorcontrib><creatorcontrib>Gunn, R.N</creatorcontrib><creatorcontrib>Matthews, J.C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nuclear medicine communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cunningham, V.J</au><au>Gunn, R.N</au><au>Matthews, J.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantification in positron emission tomography for research in pharmacology and drug development</atitle><jtitle>Nuclear medicine communications</jtitle><addtitle>Nucl Med Commun</addtitle><date>2004-07</date><risdate>2004</risdate><volume>25</volume><issue>7</issue><spage>643</spage><epage>646</epage><pages>643-646</pages><issn>0143-3636</issn><abstract>Positron emission tomography (PET) is a quantitative in vivo tracer technique, enabling images of the distribution of biochemical, physiological and pharmacological functions in living tissue, at a resolution of a few millimetres. Applications include the imaging of blood flow rate, metabolic rate and neuroreceptor distribution and function. These applications are playing an increasing role in drug development. This brief article seeks to emphasize how these applications of PET need to rest on a solid quantitative foundation.</abstract><cop>England</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>15208489</pmid><doi>10.1097/01.mnm.0000134330.38536.bc</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0143-3636
ispartof Nuclear medicine communications, 2004-07, Vol.25 (7), p.643-646
issn 0143-3636
language eng
recordid cdi_proquest_miscellaneous_66657310
source MEDLINE; Journals@Ovid Complete
subjects Algorithms
Animals
Brain - blood supply
Brain - diagnostic imaging
Brain - metabolism
Brain Mapping - methods
Drug Design
Fluorodeoxyglucose F18 - pharmacokinetics
Humans
Image Enhancement - methods
Image Interpretation, Computer-Assisted - methods
Pharmacology - methods
Positron-Emission Tomography - methods
Positron-Emission Tomography - trends
Radiopharmaceuticals - pharmacokinetics
Research Design
Sensory Receptor Cells - metabolism
title Quantification in positron emission tomography for research in pharmacology and drug development
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T23%3A40%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantification%20in%20positron%20emission%20tomography%20for%20research%20in%20pharmacology%20and%20drug%20development&rft.jtitle=Nuclear%20medicine%20communications&rft.au=Cunningham,%20V.J&rft.date=2004-07&rft.volume=25&rft.issue=7&rft.spage=643&rft.epage=646&rft.pages=643-646&rft.issn=0143-3636&rft_id=info:doi/10.1097/01.mnm.0000134330.38536.bc&rft_dat=%3Cproquest_cross%3E66657310%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66657310&rft_id=info:pmid/15208489&rfr_iscdi=true